Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaThe CDR Implementation TrialLow GI Diet in Children and Adolescents With ALLA Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-InfectionMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaSunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaAssessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerLong-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic ArthritisPediatric Philadelphia Positive Acute Lymphoblastic LeukemiaAntibiotic Safety (SCAMP)The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up HealthyIGIV Study for Chronic ITP Patients Ages 3-70Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaBiomechanical Assessment of Level Gait in Patient's Status Post Bladder ExstrophyFeasibility and Acceptability of the Hailie Monitoring System in Children With Persistent AsthmaTreating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin DiseaseSafety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaComparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaGenetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryLong-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group StudiesMetformin in Children With Relapsed or Refractory Solid TumorsPredicting Response to Standardized Pediatric Colitis TherapyImproving Medication Adherence in Pediatric Inflammatory Bowel DiseaseAcupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyBiological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory NeuroblastomaAssessing Response to Albuterol in BronchiolitisThe Genetics of Severe Asthma in ChildrenVorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaI Change Adherence & Raise ExpectationsCombination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaNivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaAn Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute LymphoblTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsBlinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed, Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma
P6153
Q44802828-ED75D7F5-ACC1-484D-8DFC-A2EDA5D81770Q47335571-58942971-824F-4FCC-8997-93644535C5D8Q50628387-D6DDF83D-B584-4C9A-9BA9-29A286B168F8Q53378802-588E5FC4-CCA8-4B54-8FFB-695C72D95B09Q59149641-E9C0D684-0D50-4B80-885D-449A38DD4FD7Q64167863-1120A753-A9AF-4E08-A6DA-5F53C82D2B15Q79211178-522D26BD-EDFC-4407-928D-2A6BC09507B1Q83510748-AF0391E9-F339-404F-9149-C6F7C9D1B23BQ87848671-E539E230-337B-4F02-8112-98679A4334EBQ88942260-2FCEE0BB-1411-41FE-A736-EFD109AAFD8AQ89643498-2DCFDE74-FFE2-4E2E-853A-636B8B027BE8Q89718556-7D70CD3B-327C-4B38-A92F-30053E72F2D6
P108
Q58407636-05524854-915F-4C62-9D9A-81E2936E1BF8Q61909108-E8395097-ED62-42F7-BA88-2CD81EE777F6Q61909515-F6A6FF5D-5E64-42C5-85B5-7EDFEAA3DF88Q61921648-E6101057-2FFA-40B7-9353-528A34FBCA83Q61936459-2F47C18C-9DB4-4F83-9842-3BEC0A3E6BFEQ61957039-25634BBD-99F2-4C4E-BA57-5DAA8AB47935Q61957392-984A5BEC-D5B6-4E1D-BB27-0AB44C7CA01FQ61957502-5EBF417C-180E-491C-B51C-9FD9B736A60AQ61957709-F9EEF428-1898-4BCC-821F-13855AD0757EQ61965726-6FBCAE45-4379-42F4-AA5B-82A43BB00505Q61969725-88B16242-6B73-4C94-B1A7-D1A59ABF9DE8Q61975143-0D8B3059-F74A-421A-9AB4-49865A2A2AE2Q61979138-B8DD84F8-E95C-4B96-80E9-8072416DE4F9Q61980425-B39773C0-9F19-47FA-B490-7E4121E20B35Q61980943-20592FD2-792E-4D7E-9DF0-B46042855A1FQ61981273-B5C11E64-67E1-4552-90F8-8ED720761424Q62025585-599973AF-79F2-452F-8299-74AC0299E3A5Q62105638-2C25E47F-E20C-47D1-B71A-81895EE3C8FFQ62105865-A0CA830A-D2F9-4AD3-B42E-9EE48669D8E7Q62106060-BC212FB8-E9FB-48DA-8F49-305B31796B2CQ62110645-2FBB6F0C-2BE6-4A11-A28F-B530FA50B1A2Q62111100-01B7AB5E-F4F6-4CB2-8833-AECC57CD7292Q62815257-F72426FA-CC68-44C3-93BC-78CDB9966652Q63063289-9FC95F60-8CD8-4F93-B773-75018E9AC8E5Q63317991-A53B9211-04A0-408A-A528-FA208DD1CACDQ63320318-958B3BD7-CF06-48A2-9667-0BDE4E56FA50Q63320327-206BD4FD-54E1-49B8-870A-F8FD01831C76Q63336137-D9F36199-DE65-4450-AE46-C40CF9688547Q63336462-D2E34795-3C34-460A-A2CC-302936B43E9FQ63340477-2D0A731E-0A17-4851-B1FB-CEFBF5C7FF4DQ63340478-01A4CB67-D943-4D7C-91DD-3B4DB6C56FE1Q63340651-D1451527-C610-414C-B345-57545ACC8EDAQ63341000-540D8D74-9BA5-419A-9485-80B1C2EF7DC9Q63341046-109A55C3-E59D-4CDA-98EE-8DF642DBCEEFQ63393377-7B0C975E-C35C-4FA3-B1E4-D0AD228418F5Q63571198-7BA8F988-EF2E-4B9C-8961-A0E4C0CCF99AQ63572193-2B7A30E5-0BFC-426D-8741-ADB91E05A1F0Q63573228-1E4C92EE-3B3E-427F-BFE0-A67CEE639F6FQ63574661-13166BE0-C16C-46B5-A3A2-3E97667DACDFQ63578202-D08F160A-F0E4-489D-955D-5FEF2EC50692
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in Connecticut, United States
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in Connecticut, Verenigde Staten van Amerika
@nl
בית חולים בארצות הברית
@he
name
Connecticut Children's Medical Center
@en
type
label
Connecticut Children's Medical Center
@en
prefLabel
Connecticut Children's Medical Center
@en
P1278
P214
P244
P3347
P1278
54930051Q0V74GIO8627
P131
P213
0000 0001 0440 7332
P214
P2427
grid.414666.7
P244
no00009704
P3347
4298366812
P3417
Connecticut-Childrens-Medical-Center
P3500
P625
Point (-72.6811 41.7547)
P6782
P7859
lccn-no00009704